Top 50 medical and healthcare startups in China

Oct 12, 2024 | By Jason Kwon

1
Funding: $288.8M
Tianjin CanSino Biotech is an emerging biotechnology company dedicated to vaccine research, development and commercialization. We seek to address the pressing unmet medical needs by developing and marketing leading-edge, high quality vaccines for China and other emerging markets at affordable prices.
2
Funding: $631.7M
Waterdrop is an online insurance technology platform that plans to solve the problem of high medical fees faced by many patients.
3
Funding: $1.5B
WeDoctor Group is an online healthcare service provider through its mobile apps and Guahao online portal
4
Funding: $1.4B
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics.
5
Funding: $920.3M
MediTrust Health is a leading medical innovation payment service brand in China.
6
Funding: $737.6M
Rakuten Aspyrian is developing tumor-targeted precision therapies based on its proprietary platform Photoimmunotherapy.
7
Funding: $682M
DXY is an online healthcare community for doctors, consumers, and healthcare organizations.
8
Funding: $343.7M
Clover Biopharmaceuticals is a clinical-stage biotechnology company focused on developing novel and transformative biologic therapies.
9
Funding: $312.5M
Ascentage Pharma is a China-based, global-oriented, clinical-stage biopharmaceutical company, dedicated to discovery and development of the “first-in-class” and the “best-in-class” targeted small-molecule cancer therapeutics.
10
Funding: $312.8M
Harbour BioMed is a global biopharmaceutical company developing innovative therapeutics in the field of immuno-oncology and inflammatory diseases.
11
Funding: $262M
D3 Bio identifies areas of unmet need in immunology and oncology and use existing clinical data to find precision medicine targets and delivery methods with the potential to improve outcomes.
12
Funding: $243.4M
Chinese smartphone app that lets users remotely consult with physicians to diagnose their ailments
13
Funding: $220M
Dingdang Health’s online-to-offline model enables it to supply drugs from the pharma manufacturers and offline pharmacies to meet users’ urgent medical needs.
14
Funding: $214.7M
Beijing Infervision is an artificial intelligence high-tech company committed to applying deep learning technology to assist medical image diagnosis as efficient and accurate solutions. Infervision effectively uses various types of medical data to create clinically valued products and promotes precision analysis in the medical field especially in assisted image diagnosis.
15
Funding: $200M
iCarbonX aims to build an ecosystem of digital life based on a combination of an individual’s biological, behavioral and psychological data, the Internet and artificial intelligence.
16
Funding: $195M
Connect Biopharmaceuticals is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
17
Funding: $190M
JW is focused on revolutionizing medicine by re-engaging the body's immune system to treat cancer.
18
Funding: CN¥1.3B
Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.
19
Funding: $179.7M
EdiGene is a biotechnology company that develops genome editing technologies.
20
Funding: $157.4M
Synyi develops hospital informatics platform with AI capabilities
Editor: Jason Kwon
Jason Kwon is a senior editor for MedicalStartups. He has previously covered the pharmaceutical and medical research industries for FDAnews and worked as a head of marketing for medical startup Sonic Therapeutics. Before that, he co-founded a startup consulting business for emerging entrepreneurial hubs in Asia. Jason graduated from St. Bonaventure University’s journalism school. In his free time, Jason enjoys yoga, watching movie trailers, traveling to places where he can't get cell service. You can contact Jason at jaskwon(at)medicalstartups(dot)com